{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:52:32Z","timestamp":1787503952123,"version":"build-2736575974"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s00210-024-03180-x","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T06:03:15Z","timestamp":1717653795000},"page":"8231-8258","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Potential applications of antofine and its synthetic derivatives in cancer therapy: structural and molecular insights"],"prefix":"10.1007","volume":"397","author":[{"given":"Iman","family":"Ramli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thamere","family":"Cheriet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duong Thi Bich","family":"Thuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dang Ngoc","family":"Khoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doan Nguyen Khanh","family":"Thu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Posadino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Fenu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Sharifi-Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Pintus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,6]]},"reference":[{"issue":"5629","key":"3180_CR1","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1126\/science.1082015","volume":"301","author":"A Alavi","year":"2003","unstructured":"Alavi A et al (2003) Role of Raf in vascular protection from distinct apoptotic stimuli. Science 301(5629):94\u201396","journal-title":"Science"},{"issue":"2","key":"3180_CR2","first-page":"188","volume":"56","author":"M Ali","year":"2001","unstructured":"Ali M, Ansari SH, Grever MR (2001) Cytotoxic alkaloids from Tylophora indica. Pharmazie 56(2):188\u2013190","journal-title":"Pharmazie"},{"issue":"26","key":"3180_CR3","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.1016\/j.tet.2010.03.021","volume":"66","author":"LM Ambrosini","year":"2010","unstructured":"Ambrosini LM, Cernak TA, Lambert TH (2010) Total synthesis of the tylophora alkaloids rusplinone, 13a\u03b1-secoantofine, and antofine using a multicatalytic oxidative aminochlorocarbonylation\/Friedel\u2013Crafts reaction. Tetrahedron 66(26):4882\u20134887","journal-title":"Tetrahedron"},{"issue":"8","key":"3180_CR4","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S0031-9422(01)00382-X","volume":"58","author":"T-Y An","year":"2001","unstructured":"An T-Y et al (2001) Alkaloids from Cynanchum komarovii with inhibitory activity against the tobacco mosaic virus. Phytochemistry 58(8):1267\u20131269","journal-title":"Phytochemistry"},{"issue":"44","key":"3180_CR5","doi-asserted-by":"publisher","first-page":"12591","DOI":"10.1002\/slct.201803529","volume":"3","author":"A Ansari","year":"2018","unstructured":"Ansari A, Ramapanicker R (2018) Enantioselective synthesis of (R)-antofine and (R)-cryptopleurine. ChemistrySelect 3(44):12591\u201312594","journal-title":"ChemistrySelect"},{"issue":"2","key":"3180_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/med.21417","volume":"37","author":"S Bansal","year":"2017","unstructured":"Bansal S et al (2017) Topoisomerases: resistance versus sensitivity, how far we can go? Med Res Rev 37(2):404\u2013438","journal-title":"Med Res Rev"},{"issue":"07","key":"3180_CR7","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1055\/s-2006-962239","volume":"55","author":"B Baumgartner","year":"1989","unstructured":"Baumgartner B et al (1989) Antofine, a strong antifungal alkaloid from Ficus septica leaves. Planta Med 55(07):652\u2013653","journal-title":"Planta Med"},{"key":"3180_CR8","doi-asserted-by":"crossref","unstructured":"Bhakuni DS, Gupta PK (1982) Synthesis of (.+\u2010.)\u2010antofine and (.+\u2010.)\u2010alkaloid\u2010C. Indian J Chem Sect B: Org Chem Incl Med Chem 21:393","DOI":"10.1002\/chin.198249315"},{"issue":"12","key":"3180_CR9","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/nrm1261","volume":"4","author":"C Birchmeier","year":"2003","unstructured":"Birchmeier C et al (2003) Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4(12):915\u2013925","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"3180_CR10","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.2174\/1871520614666140624110458","volume":"14","author":"T Bour","year":"2014","unstructured":"Bour T et al (2014) Differential effects of antofine N-oxide on solid tumor and leukemia cells. Anti-Cancer Agents Med Chem (Formerly Current Medicinal Chemistry-Anti-Cancer Agents) 14(10):1315\u20131323","journal-title":"Anti-Cancer Agents Med Chem (Formerly Current Medicinal Chemistry-Anti-Cancer Agents)"},{"issue":"21","key":"3180_CR11","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1021\/jo00169a009","volume":"48","author":"ML Bremmer","year":"1983","unstructured":"Bremmer ML, Khatri NA, Weinreb SM (1983) Quinolizidine alkaloid synthesis via the intramolecular imino Diels-alder reaction cryptopleurine. J Org Chem 48(21):3661\u20133666","journal-title":"J Org Chem"},{"issue":"2","key":"3180_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2174\/1568026613666131213154633","volume":"14","author":"ACB Burtoloso","year":"2014","unstructured":"Burtoloso ACB, Bertonha AF, Rosset IG (2014) Synthesis of alkaloids: recent advances in the synthesis of phenanthroindolizidine alkaloids. Curr Top Med Chem 14(2):191\u2013199","journal-title":"Curr Top Med Chem"},{"issue":"1","key":"3180_CR13","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1080\/14756366.2020.1821676","volume":"35","author":"K Buzun","year":"2020","unstructured":"Buzun K et al (2020) DNA topoisomerases as molecular targets for anticancer drugs. J Enzyme Inhib Med Chem 35(1):1781\u20131799","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"7","key":"3180_CR14","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1021\/np060081y","volume":"69","author":"XF Cai","year":"2006","unstructured":"Cai XF et al (2006) Phenanthroquinolizidine alkaloids from the roots of Boehmeria pannosa potently inhibit hypoxia-inducible factor-1 in AGS human gastric cancer cells. J Nat Prod 69(7):1095\u20131097","journal-title":"J Nat Prod"},{"key":"3180_CR15","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s12094-010-0501-0","volume":"12","author":"I Canadas","year":"2010","unstructured":"Canadas I et al (2010) C-MET as a new therapeutic target for the development of novel anticancer drugs. Clin Transl Oncol 12:253\u2013260","journal-title":"Clin Transl Oncol"},{"issue":"2","key":"3180_CR16","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1021\/np50062a030","volume":"52","author":"M Capo","year":"1989","unstructured":"Capo M, Saa J (1989) (\u2013)-Antofine: a phenanthroindolizidine from Vincetaxicum nigrum. J Nat Prod 52(2):389\u2013390","journal-title":"J Nat Prod"},{"key":"3180_CR17","unstructured":"Cassady JM, Douros J (1980) Anticancer agents based on natural product models. Medicinal Chemistry, Vol 6. Academic Press, New York"},{"issue":"12","key":"3180_CR18","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1071\/CH9892243","volume":"42","author":"A Cave","year":"1989","unstructured":"Cave A et al (1989) Alkaloids of Cryptocarya phyllostemon. Aust J Chem 42(12):2243\u20132263","journal-title":"Aust J Chem"},{"issue":"1","key":"3180_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/157340709787580928","volume":"5","author":"RS Chemler","year":"2009","unstructured":"Chemler RS (2009) Phenanthroindolizidines and Phenanthroquinolizidines: promising Alkaloids for Anti-Cancer Therapy. Curr Bioact Compd 5(1):2\u201319","journal-title":"Curr Bioact Compd"},{"issue":"9","key":"3180_CR20","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.bcp.2013.02.009","volume":"85","author":"M-C Chen","year":"2013","unstructured":"Chen M-C et al (2013) Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1\u03b1\/VEGF signaling pathway in human bladder cancer cells. Biochem Pharmacol 85(9):1278\u20131287","journal-title":"Biochem Pharmacol"},{"issue":"83","key":"3180_CR21","doi-asserted-by":"publisher","first-page":"79958","DOI":"10.1039\/C6RA16455B","volume":"6","author":"C-Y Chen","year":"2016","unstructured":"Chen C-Y et al (2016) Phenanthroindolizidine alkaloids from Tylophora atrofolliculata with hypoxia-inducible factor-1 (HIF-1) inhibitory activity. RSC Adv 6(83):79958\u201379967","journal-title":"RSC Adv"},{"key":"3180_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.phytol.2019.03.003","volume":"31","author":"C-Y Chen","year":"2019","unstructured":"Chen C-Y et al (2019) A phenanthroindolizidine glycoside with HIF-1 inhibitory activity from Tylophora atrofolliculata. Phytochem Lett 31:39\u201342","journal-title":"Phytochem Lett"},{"key":"3180_CR23","doi-asserted-by":"publisher","unstructured":"Chen J-X et al (2020) Cynanchum paniculatum and its major active constituents for inflammatory-related diseases: a review of traditional use, multiple pathway modulations, and clinical applications. Evid Based Complement Alternat Med\u00a02020:7259686.\u00a0https:\/\/doi.org\/10.1155\/2020\/7259686","DOI":"10.1155\/2020\/7259686"},{"issue":"2","key":"3180_CR24","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1042\/bj20020098","volume":"366","author":"AR Chowdhury","year":"2002","unstructured":"Chowdhury AR et al (2002) Luteolin, an emerging anti-cancer flavonoid, poisons eukaryotic DNA topoisomerase I. Biochem J 366(2):653\u2013661","journal-title":"Biochem J"},{"issue":"5","key":"3180_CR25","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.bcp.2012.11.001","volume":"85","author":"S Coni","year":"2013","unstructured":"Coni S, Infante P, Gulino A (2013) Control of stem cells and cancer stem cells by Hedgehog signaling: pharmacologic clues from pathway dissection. Biochem Pharmacol 85(5):623\u2013628","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"3180_CR26","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3322\/caac.20075","volume":"60","author":"KM Cook","year":"2010","unstructured":"Cook KM, Figg WD (2010) Angiogenesis inhibitors: current strategies and future prospects. CA Cancer J Clin 60(4):222\u2013243","journal-title":"CA Cancer J Clin"},{"issue":"20","key":"3180_CR27","doi-asserted-by":"publisher","first-page":"7018","DOI":"10.1021\/jo101510x","volume":"75","author":"M Cui","year":"2010","unstructured":"Cui M et al (2010) Asymmetric Synthesis of (R)-antofine and (R)-Cryptopleurine via Proline-Catalyzed Sequential \u03b1-Aminoxylation and Horner\u2212 Wadsworth\u2212 Emmons Olefination of Aldehyde. J Org Chem 75(20):7018\u20137021","journal-title":"J Org Chem"},{"issue":"10","key":"3180_CR28","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1055\/s-0029-1185483","volume":"75","author":"AG Damu","year":"2009","unstructured":"Damu AG et al (2009) Cytotoxic phenanthroindolizidine alkaloids from the roots of Ficus septica. Planta Med 75(10):1152\u20131156","journal-title":"Planta Med"},{"issue":"9","key":"3180_CR29","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.2174\/1871520615666150520143600","volume":"15","author":"M de Fatima Pereira","year":"2015","unstructured":"de Fatima Pereira M, Rochais C, Dallemagne P (2015) Recent advances in phenanthroindolizidine and phenanthroquinolizidine derivatives with anticancer activities. Anti-Cancer Agents Med Chem 15(9):1080\u20131091","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"3180_CR30","first-page":"1171","volume":"7","author":"M Dhiman","year":"2012","unstructured":"Dhiman M et al (2012) Antifungal activity of hydrochloride salts of tylophorinidine and tylophorinine. Nat Prod Commun 7:1171\u20131172","journal-title":"Nat Prod Commun"},{"issue":"13","key":"3180_CR31","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1021\/bi00256a023","volume":"21","author":"H Doelz","year":"1982","unstructured":"Doelz H, Vazquez D, Jimenez A (1982) Quantitation of the specific interaction of [14a-3H] cryptopleurine with 80S and 40S ribosomal species from the yeast Saccharomyces cerevisiae. Biochemistry 21(13):3181\u20133187","journal-title":"Biochemistry"},{"issue":"1","key":"3180_CR32","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/0006-291X(68)90037-5","volume":"31","author":"GR Donaldson","year":"1968","unstructured":"Donaldson GR, Atkinson MR, Murray AW (1968) Inhibition of protein synthesis in Ehrlich ascites-tumour cells by the phenanthrene alkaloids tylophorine, tylocrebrine and cryptopleurine. Biochem Biophys Res Commun 31(1):104\u2013109","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"3180_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev.bi.58.070189.001033","volume":"58","author":"JA Endicott","year":"1989","unstructured":"Endicott JA, Ling V (1989) The biochemistry of p-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 58(1):137\u2013171","journal-title":"Annu Rev Biochem"},{"issue":"4","key":"3180_CR34","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1210\/er.2003-0027","volume":"25","author":"N Ferrara","year":"2004","unstructured":"Ferrara N (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25(4):581\u2013611","journal-title":"Endocr Rev"},{"issue":"6","key":"3180_CR35","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nm0603-669","volume":"9","author":"N Ferrara","year":"2003","unstructured":"Ferrara N, Gerber H-P, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9(6):669\u2013676","journal-title":"Nat Med"},{"issue":"1","key":"3180_CR36","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1074\/jbc.M109.029637","volume":"285","author":"KG Foster","year":"2010","unstructured":"Foster KG et al (2010) Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation. J Biol Chem 285(1):80\u201394","journal-title":"J Biol Chem"},{"issue":"1","key":"3180_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.bmcl.2006.09.080","volume":"17","author":"Y Fu","year":"2007","unstructured":"Fu Y et al (2007) Synthesis and structure\u2013activity studies of antofine analogues as potential anticancer agents. Bioorg Med Chem Lett 17(1):97\u2013100","journal-title":"Bioorg Med Chem Lett"},{"issue":"28","key":"3180_CR38","doi-asserted-by":"publisher","first-page":"7398","DOI":"10.1002\/chem.200600592","volume":"12","author":"A F\u00fcrstner","year":"2006","unstructured":"F\u00fcrstner A, Kennedy JWJ (2006) Total syntheses of the Tylophora alkaloids cryptopleurine, (\u2212)\u2010antofine, (\u2212)\u2010tylophorine, and (\u2212)\u2010ficuseptine C. Chem Eur J 12(28):7398\u20137410","journal-title":"Chem Eur J"},{"issue":"2","key":"3180_CR39","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1158\/0008-5472.CAN-03-1904","volume":"64","author":"W Gao","year":"2004","unstructured":"Gao W et al (2004) Novel mode of action of tylophorine analogs as antitumor compounds. Can Res 64(2):678\u2013688","journal-title":"Can Res"},{"issue":"15","key":"3180_CR40","doi-asserted-by":"publisher","first-page":"4338","DOI":"10.1016\/j.bmcl.2007.05.021","volume":"17","author":"W Gao","year":"2007","unstructured":"Gao W et al (2007a) Structure\u2013activity studies of phenanthroindolizidine alkaloids as potential antitumor agents. Bioorg Med Chem Lett 17(15):4338\u20134342","journal-title":"Bioorg Med Chem Lett"},{"issue":"15","key":"3180_CR41","doi-asserted-by":"publisher","first-page":"4338","DOI":"10.1016\/j.bmcl.2007.05.021","volume":"17","author":"W Gao","year":"2007","unstructured":"Gao W et al (2007b) Structure-activity studies of phenanthroindolizidine alkaloids as potential antitumor agents. Bioorg Med Chem Lett 17(15):4338\u20134342","journal-title":"Bioorg Med Chem Lett"},{"issue":"9","key":"3180_CR42","doi-asserted-by":"publisher","first-page":"17483","DOI":"10.3390\/molecules200917483","volume":"20","author":"Y Ge","year":"2015","unstructured":"Ge Y et al (2015) Insecticidal constituents and activity of alkaloids from Cynanchum mongolicum. Mol 20(9):17483\u201317492","journal-title":"Mol"},{"issue":"1","key":"3180_CR43","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1021\/np50019a005","volume":"45","author":"E Gellert","year":"1982","unstructured":"Gellert E (1982) The indolizidine alkaloids. J Nat Prod 45(1):50\u201373","journal-title":"J Nat Prod"},{"issue":"2","key":"3180_CR44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrc3205","volume":"12","author":"E Gherardi","year":"2012","unstructured":"Gherardi E et al (2012) Targeting MET in cancer: rationale and progress. Nat Rev Cancer 12(2):89\u2013103","journal-title":"Nat Rev Cancer"},{"key":"3180_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.894305","volume":"10","author":"R Giordo","year":"2022","unstructured":"Giordo R et al (2022a) Disease-associated regulation of non-coding RNAs by resveratrol: molecular insights and therapeutic applications. Front Cell Dev Biol 10:894305","journal-title":"Front Cell Dev Biol"},{"key":"3180_CR46","doi-asserted-by":"crossref","unstructured":"Giordo R et al (2022b) Nano-targeting vascular remodeling in cancer: recent developments and future directions. Sem Cancer Biol 86(Pt 2):784\u2013804","DOI":"10.1016\/j.semcancer.2022.03.001"},{"issue":"1","key":"3180_CR47","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrc706","volume":"2","author":"MM Gottesman","year":"2002","unstructured":"Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP\u2013dependent transporters. Nat Rev Cancer 2(1):48\u201358","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"3180_CR48","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1002\/cbdv.200890124","volume":"5","author":"H-J Han","year":"2008","unstructured":"Han H-J et al (2008) Natural inhibitors of DNA topoisomerase I with cytotoxicities. Chem Biodivers 5(7):1364\u20131368","journal-title":"Chem Biodivers"},{"issue":"20","key":"3180_CR49","doi-asserted-by":"publisher","first-page":"5334","DOI":"10.1021\/ol4025925","volume":"15","author":"G Han","year":"2013","unstructured":"Han G, Liu Y, Wang Q (2013) Total synthesis of phenanthroindolizidine alkaloids through an amidyl radical cascade\/rearrangement reaction. Org Lett 15(20):5334\u20135337","journal-title":"Org Lett"},{"issue":"1","key":"3180_CR50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57\u201370","journal-title":"Cell"},{"issue":"4","key":"3180_CR51","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1016\/S0021-9258(18)53865-5","volume":"268","author":"CE Herzog","year":"1993","unstructured":"Herzog CE et al (1993) Increased mdr-1\/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists. J Biol Chem 268(4):2946\u20132952","journal-title":"J Biol Chem"},{"issue":"27","key":"3180_CR52","doi-asserted-by":"publisher","first-page":"14873","DOI":"10.1016\/S0021-9258(17)38654-4","volume":"260","author":"YH Hsiang","year":"1985","unstructured":"Hsiang YH et al (1985) Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem 260(27):14873\u201314878","journal-title":"J Biol Chem"},{"key":"3180_CR53","unstructured":"Hsiang YH, Liu LF (1988) Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin.\u00a0Cancer Res\u00a048(7):1722-6"},{"issue":"5","key":"3180_CR54","first-page":"538","volume":"8","author":"M-T Huang","year":"1972","unstructured":"Huang M-T, Grollman AP (1972) Mode of action of tylocrebrine: effects on protein and nucleic acid synthesis. Mol Pharmacol 8(5):538\u2013550","journal-title":"Mol Pharmacol"},{"key":"3180_CR55","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.neuro.2013.02.001","volume":"35","author":"Y-F Huang","year":"2013","unstructured":"Huang Y-F et al (2013) Antofine-induced connexin43 gap junction disassembly in rat astrocytes involves protein kinase C\u03b2. Neurotoxicology 35:169\u2013179","journal-title":"Neurotoxicology"},{"issue":"12","key":"3180_CR56","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.2174\/092986708784310459","volume":"15","author":"M Hwang","year":"2008","unstructured":"Hwang M et al (2008) The mTOR signaling network: insights from its role during embryonic development. Curr Med Chem 15(12):1192\u20131208","journal-title":"Curr Med Chem"},{"issue":"19","key":"3180_CR57","doi-asserted-by":"publisher","first-page":"5978","DOI":"10.1016\/j.bmcl.2011.07.120","volume":"21","author":"T Ikeda","year":"2011","unstructured":"Ikeda T et al (2011) Synthesis of phenanthroindolizidine alkaloids and evaluation of their antitumor activities and toxicities. Bioorg Med Chem Lett 21(19):5978\u20135981","journal-title":"Bioorg Med Chem Lett"},{"issue":"25","key":"3180_CR58","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/S0040-4039(01)82903-8","volume":"22","author":"M Iwao","year":"1981","unstructured":"Iwao M et al (1981) Directed metalation of tertiary benzamides. Abbreviated syntheses of phenanthro-quinolizidine and-indolizidine alkaloids. Tetrahedron Lett 22(25):2349\u20132352","journal-title":"Tetrahedron Lett"},{"issue":"12","key":"3180_CR59","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/S0040-4020(01)91913-1","volume":"39","author":"M Iwao","year":"1983","unstructured":"Iwao M et al (1983) Directed ortho metallation of tertiary aromatic amides: a new n-heteroring annelation method and synthesis of phenanthro-quinolizidine and-indolizidine alkaloids. Tetrahedron 39(12):1955\u20131962","journal-title":"Tetrahedron"},{"issue":"4","key":"3180_CR60","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s11101-020-09723-3","volume":"20","author":"X-H Jia","year":"2021","unstructured":"Jia X-H et al (2021) Possible pharmaceutical applications can be developed from naturally occurring phenanthroindolizidine and phenanthroquinolizidine alkaloids. Phytochem Rev 20(4):845\u2013868","journal-title":"Phytochem Rev"},{"issue":"1","key":"3180_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40675-017-0062-7","volume":"3","author":"JC Jun","year":"2017","unstructured":"Jun JC et al (2017) Hypoxia-inducible factors and cancer. Current Sleep Medicine Reports 3(1):1\u201310","journal-title":"Current Sleep Medicine Reports"},{"issue":"1","key":"3180_CR62","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12272-013-0276-2","volume":"37","author":"G Kibria","year":"2014","unstructured":"Kibria G, Hatakeyama H, Harashima H (2014) Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system. Arch Pharmacal Res 37(1):4\u201315","journal-title":"Arch Pharmacal Res"},{"issue":"15","key":"3180_CR63","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1021\/ol0349007","volume":"5","author":"S Kim","year":"2003","unstructured":"Kim S et al (2003) First asymmetric total synthesis of (\u2212)-antofine by using an enantioselective catalytic phase transfer alkylation. Org Lett 5(15):2703\u20132706","journal-title":"Org Lett"},{"issue":"13","key":"3180_CR64","doi-asserted-by":"publisher","first-page":"4886","DOI":"10.1021\/jo070668x","volume":"72","author":"S Kim","year":"2007","unstructured":"Kim S et al (2007) Expedient syntheses of antofine and cryptopleurine via intramolecular 1, 3-dipolar cycloaddition. J Org Chem 72(13):4886\u20134891","journal-title":"J Org Chem"},{"issue":"3\u20134","key":"3180_CR65","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.fct.2011.11.008","volume":"50","author":"E-H Kim","year":"2012","unstructured":"Kim E-H et al (2012) Anti-proliferative activity and suppression of P-glycoprotein by (\u2212)-antofine, a natural phenanthroindolizidine alkaloid, in paclitaxel-resistant human lung cancer cells. Food Chem Toxicol 50(3\u20134):1060\u20131065","journal-title":"Food Chem Toxicol"},{"issue":"10","key":"3180_CR66","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1021\/np50088a010","volume":"55","author":"Y Konda","year":"1992","unstructured":"Konda Y et al (1992) Two new glycosides, hancoside and neohancoside A, from Cynanchum hancockianum. J Nat Prod 55(10):1447\u20131453","journal-title":"J Nat Prod"},{"issue":"4","key":"3180_CR67","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.bmc.2012.11.039","volume":"21","author":"Y Kwon","year":"2013","unstructured":"Kwon Y et al (2013) Design, synthesis, and evaluation of a water-soluble antofine analogue with high antiproliferative and antitumor activity. Bioorg Med Chem 21(4):1006\u20131017","journal-title":"Bioorg Med Chem"},{"issue":"19","key":"3180_CR68","doi-asserted-by":"publisher","first-page":"7749","DOI":"10.1021\/acs.jmedchem.5b00764","volume":"58","author":"Y Kwon","year":"2015","unstructured":"Kwon Y et al (2015) Design, synthesis, and biological activity of sulfonamide analogues of antofine and cryptopleurine as potent and orally active antitumor agents. J Med Chem 58(19):7749\u20137762","journal-title":"J Med Chem"},{"issue":"15","key":"3180_CR69","doi-asserted-by":"publisher","first-page":"6620","DOI":"10.1021\/jo3011045","volume":"77","author":"G Lahm","year":"2012","unstructured":"Lahm G, Stoye A, Opatz T (2012) A five-step synthesis of (\u00b1)-tylophorine via a nitrile- stabilized ammonium ylide. J Org Chem 77(15):6620\u20136623","journal-title":"J Org Chem"},{"key":"3180_CR70","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0031-6865(94)90052-3","volume":"68","author":"M Lavanlt","year":"1994","unstructured":"Lavanlt M, Richomme P, Bruneton J (1994) New phenath-roindolizidine N-oxides alkaloids isolated from Vincetoxicum hirudinaria. Pharm Acta Helv 68:225\u2013227","journal-title":"Pharm Acta Helv"},{"issue":"01","key":"3180_CR71","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1055\/s-2003-37021","volume":"69","author":"SK Lee","year":"2003","unstructured":"Lee SK, Nam K-A, Heo Y-H (2003) Cytotoxic activity and G2\/M cell cycle arrest mediated by antofine, a phenanthroindolizidine alkaloid isolated from Cynanchum paniculatum. Planta Med 69(01):21\u201325","journal-title":"Planta Med"},{"issue":"3","key":"3180_CR72","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cell.2007.05.058","volume":"130","author":"D-F Lee","year":"2007","unstructured":"Lee D-F et al (2007) IKK\u03b2 suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 130(3):440\u2013455","journal-title":"Cell"},{"issue":"23","key":"3180_CR73","doi-asserted-by":"publisher","first-page":"10363","DOI":"10.1021\/jm300705j","volume":"55","author":"Y-Z Lee","year":"2012","unstructured":"Lee Y-Z et al (2012) Synthesis and biological evaluation of tylophorine-derived dibenzoquinolines as orally active agents: exploration of the role of tylophorine e ring on biological activity. J Med Chem 55(23):10363\u201310377","journal-title":"J Med Chem"},{"issue":"1","key":"3180_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030342","volume":"7","author":"H Lv","year":"2012","unstructured":"Lv H et al (2012) Synthesis, biological evaluation and mechanism studies of deoxytylophorinine and its derivatives as potential anticancer agents. PLoS ONE 7(1):e30342","journal-title":"PLoS ONE"},{"issue":"9","key":"3180_CR75","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1021\/np0106384","volume":"65","author":"AK Lykkeberg","year":"2002","unstructured":"Lykkeberg AK et al (2002) In vitro cytotoxic activity of phenanthroindolizidine alkaloids from Cynanchum vincetoxicum and Tylophora tanakae against drug-sensitive and multidrug-resistant cancer cells. J Nat Prod 65(9):1299\u20131302","journal-title":"J Nat Prod"},{"issue":"3","key":"3180_CR76","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0014-2999(00)00047-9","volume":"391","author":"C Marbeuf-Gueye","year":"2000","unstructured":"Marbeuf-Gueye C et al (2000) Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P. Eur J Pharmacol 391(3):207\u2013216","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"3180_CR77","first-page":"561","volume":"16","author":"W Meng","year":"2018","unstructured":"Meng W et al (2018) Application of alkaloids in reversing multidrug resistance in human cancers. Chin J Nat Med 16(8):561\u2013571","journal-title":"Chin J Nat Med"},{"issue":"9","key":"3180_CR78","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.bcp.2010.07.026","volume":"80","author":"H-Y Min","year":"2010","unstructured":"Min H-Y et al (2010) Inhibition of cell growth and potentiation of tumor necrosis factor-\u03b1 (TNF-\u03b1)-induced apoptosis by a phenanthroindolizidine alkaloid antofine in human colon cancer cells. Biochem Pharmacol 80(9):1356\u20131364","journal-title":"Biochem Pharmacol"},{"issue":"5\u20136","key":"3180_CR79","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.bse.2008.01.001","volume":"36","author":"C Mogg","year":"2008","unstructured":"Mogg C et al (2008) Tests of the antibiotic properties of the invasive vine Vincetoxicum rossicum against bacteria, fungi and insects. Biochem Syst Ecol 36(5\u20136):383\u2013391","journal-title":"Biochem Syst Ecol"},{"issue":"12","key":"3180_CR80","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P","volume":"21","author":"PJ Morin","year":"1999","unstructured":"Morin PJ (1999) \u03b2-catenin signaling and cancer. BioEssays 21(12):1021\u20131030","journal-title":"BioEssays"},{"key":"3180_CR81","doi-asserted-by":"crossref","unstructured":"Muz B et al (2015) The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia (Auckl) 3:83\u201392","DOI":"10.2147\/HP.S93413"},{"issue":"33","key":"3180_CR82","doi-asserted-by":"publisher","first-page":"31000","DOI":"10.1074\/jbc.M300643200","volume":"278","author":"D Nagata","year":"2003","unstructured":"Nagata D, Mogi M, Walsh K (2003) AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress*. J Biol Chem 278(33):31000\u201331006","journal-title":"J Biol Chem"},{"issue":"2","key":"3180_CR83","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/hr.2008.25","volume":"32","author":"D Nagata","year":"2009","unstructured":"Nagata D et al (2009) A new constitutively active mutant of AMP-activated protein kinase inhibits anoxia-induced apoptosis of vascular endothelial cell. Hypertens Res 32(2):133\u2013139","journal-title":"Hypertens Res"},{"issue":"2","key":"3180_CR84","first-page":"582","volume":"8","author":"M Naito","year":"2002","unstructured":"Naito M et al (2002) MS-209, a Quinoline-type reversal agent, potentiates antitumor efficacy of docetaxel in multidrug-resistant solid tumor xenograft models1. Clin Cancer Res 8(2):582\u2013588","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3180_CR85","first-page":"117","volume":"3","author":"M Nemat Alla","year":"2012","unstructured":"Nemat Alla M et al (2012) Ecophysiological study on the invasive weed Cynanchum acutum L. J Plant Prod 3(1):117\u2013129","journal-title":"J Plant Prod"},{"issue":"17","key":"3180_CR86","doi-asserted-by":"publisher","first-page":"6019","DOI":"10.1021\/jo101051w","volume":"75","author":"MJ Niphakis","year":"2010","unstructured":"Niphakis MJ, Georg GI (2010) Total syntheses of arylindolizidine alkaloids (+)-ipalbidine and (+)-antofine. J Org Chem 75(17):6019\u20136022","journal-title":"J Org Chem"},{"key":"3180_CR87","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.fct.2017.06.036","volume":"107","author":"J Oh","year":"2017","unstructured":"Oh J et al (2017) Antofine, a natural phenanthroindolizidine alkaloid, suppresses angiogenesis via regulation of AKT\/mTOR and AMPK pathway in endothelial cells and endothelial progenitor cells derived from mouse embryonic stem cells. Food Chem Toxicol 107:201\u2013207","journal-title":"Food Chem Toxicol"},{"issue":"12","key":"3180_CR88","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1248\/cpb.c19-00692","volume":"67","author":"Z Omran","year":"2019","unstructured":"Omran Z et al (2019) Boronic analogues of (R)-6-O-desmethylantofine as anticancer agents. Chem Pharm Bull 67(12):1324\u20131327","journal-title":"Chem Pharm Bull"},{"key":"3180_CR89","doi-asserted-by":"publisher","unstructured":"Omran Z et al (2021) Design, synthesis and in-vitro biological evaluation of antofine and tylophorine prodrugs as hypoxia-targeted anticancer agents. Mol 26(11). https:\/\/doi.org\/10.3390\/molecules26113327","DOI":"10.3390\/molecules26113327"},{"issue":"10","key":"3180_CR90","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1021\/jo400659n","volume":"78","author":"JC Orejarena Pacheco","year":"2013","unstructured":"Orejarena Pacheco JC, Lahm G, Opatz T (2013) Synthesis of alkaloids by stevens rearrangement of nitrile-stabilized ammonium ylides: (\u00b1)-laudanosine, (\u00b1)-laudanidine, (\u00b1)-armepavine, (\u00b1)-7-methoxycryptopleurine, and (\u00b1)-xylopinine. J Org Chem 78(10):4985\u20134992","journal-title":"J Org Chem"},{"key":"3180_CR91","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.phytol.2017.07.002","volume":"21","author":"WNNW Othman","year":"2017","unstructured":"Othman WNNW et al (2017) Alkaloids from Cryptocarya densiflora Blume (Lauraceae) and their cholinesterase inhibitory activity. Phytochem Lett 21:230\u2013236","journal-title":"Phytochem Lett"},{"issue":"11","key":"3180_CR92","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.2174\/0929867327999200730173748","volume":"28","author":"P Paliogiannis","year":"2021","unstructured":"Paliogiannis P et al (2021) Repurposing anticancer drugs for the treatment of idiopathic pulmonary fibrosis and antifibrotic drugs for the treatment of cancer: state of the art. Curr Med Chem 28(11):2234\u20132247","journal-title":"Curr Med Chem"},{"key":"3180_CR93","first-page":"259","volume":"28","author":"TF Platonova","year":"1958","unstructured":"Platonova TF, Kuzovkov AD, Massagetov PS (1958) Aconite alkaloids. IX. Alkaloids of Aconitum excelsum. J Gen Chem USSR 28:259\u2013261","journal-title":"J Gen Chem USSR"},{"key":"3180_CR94","unstructured":"Ponomarenko M et al (2013) Brenner\u2019s encyclopedia of genetics, 2nd edition. Elsevier"},{"key":"3180_CR95","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.tiv.2017.05.005","volume":"42","author":"AM Posadino","year":"2017","unstructured":"Posadino AM et al (2017) Oxidative stress-induced Akt downregulation mediates green tea toxicity towards prostate cancer cells. Toxicol in Vitro 42:255\u2013262","journal-title":"Toxicol in Vitro"},{"key":"3180_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114783","volume":"163","author":"AM Posadino","year":"2023","unstructured":"Posadino AM et al (2023a) An updated overview of cyanidins for chemoprevention and cancer therapy. Biomed Pharmacother 163:114783","journal-title":"Biomed Pharmacother"},{"key":"3180_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114866","volume":"163","author":"AM Posadino","year":"2023","unstructured":"Posadino AM et al (2023b) Medicinal and mechanistic overview of artemisinin in the treatment of human diseases. Biomed Pharmacother 163:114866","journal-title":"Biomed Pharmacother"},{"key":"3180_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/3149223","volume":"2021","author":"C Quispe","year":"2021","unstructured":"Quispe C et al (2021) Nanoderived therapeutic formulations with curcumin in inflammation-related diseases. Oxid Med Cell Longev 2021:1\u201315","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"3180_CR99","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1021\/jm1013715","volume":"54","author":"V Sanna","year":"2011","unstructured":"Sanna V et al (2011a) Targeted biocompatible nanoparticles for the delivery of (\u2212)-epigallocatechin 3-gallate to prostate cancer cells. J Med Chem 54(5):1321\u20131332","journal-title":"J Med Chem"},{"key":"3180_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1556-276X-6-260","volume":"6","author":"V Sanna","year":"2011","unstructured":"Sanna V et al (2011b) Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies. Nanoscale Res Lett 6:1\u20139","journal-title":"Nanoscale Res Lett"},{"issue":"3","key":"3180_CR101","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s10555-007-9077-8","volume":"26","author":"H Seeliger","year":"2007","unstructured":"Seeliger H et al (2007) Role of mTOR in solid tumor systems: a therapeutical target against primary tumor growth, metastases, and angiogenesis. Cancer Metastasis Rev 26(3):611\u2013621","journal-title":"Cancer Metastasis Rev"},{"issue":"13","key":"3180_CR102","doi-asserted-by":"publisher","first-page":"5680","DOI":"10.1073\/pnas.88.13.5680","volume":"88","author":"GL Semenza","year":"1991","unstructured":"Semenza GL et al (1991) Hypoxia-inducible nuclear factors bind to an enhancer element located 3\u2019to the human erythropoietin gene. Proc Natl Acad Sci 88(13):5680\u20135684","journal-title":"Proc Natl Acad Sci"},{"issue":"19_Supplement","key":"3180_CR103","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.1158\/1538-7445.AM2014-4236","volume":"74","author":"J Song","year":"2014","unstructured":"Song J et al (2014) Abstract 4236: Antitumor activity of a novel (-)-antofine analog in human lung cancer cells and paclitaxel-resistant lung cancer cells. Cancer Res 74(19_Supplement):4236\u20134236","journal-title":"Cancer Res"},{"issue":"4","key":"3180_CR104","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.chembiol.2015.03.011","volume":"22","author":"J Song","year":"2015","unstructured":"Song J et al (2015) Antitumor activity of phenanthroindolizidine alkaloids is associated with negative regulation of Met endosomal signaling in renal cancer cells. Chem Biol 22(4):504\u2013515","journal-title":"Chem Biol"},{"issue":"2","key":"3180_CR105","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S1368-7646(03)00005-0","volume":"6","author":"A Sparreboom","year":"2003","unstructured":"Sparreboom A et al (2003) Pharmacogenomics of ABC transporters and its role in cancer chemotherapy. Drug Resist Updates 6(2):71\u201384","journal-title":"Drug Resist Updates"},{"issue":"9","key":"3180_CR106","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1021\/np0106384","volume":"65","author":"D St\u00e6rk","year":"2002","unstructured":"St\u00e6rk D et al (2002) In vitro cytotoxic activity of phenanthroindolizidine alkaloids from cynanchum v incetoxicum and tylophora t anakae against drug-sensitive and multidrug-resistant cancer cells. J Nat Prod 65(9):1299\u20131302","journal-title":"J Nat Prod"},{"issue":"9","key":"3180_CR107","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.bse.2005.01.004","volume":"33","author":"D St\u00e6rk","year":"2005","unstructured":"St\u00e6rk D et al (2005) Phenanthroindolizidine alkaloids from Vincetoxicum pumilum. Biochem Syst Ecol 33(9):957\u2013960","journal-title":"Biochem Syst Ecol"},{"issue":"3","key":"3180_CR108","doi-asserted-by":"publisher","first-page":"192","DOI":"10.18632\/aging.100296","volume":"3","author":"LS Steelman","year":"2011","unstructured":"Steelman LS et al (2011) Roles of the Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Aging (albany NY) 3(3):192","journal-title":"Aging (albany NY)"},{"issue":"11","key":"3180_CR109","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1517\/13543784.2010.522988","volume":"19","author":"GM Stella","year":"2010","unstructured":"Stella GM, Benvenuti S, Comoglio PM (2010) Targeting the MET oncogene in cancer and metastases. Expert Opin Investig Drugs 19(11):1381\u20131394","journal-title":"Expert Opin Investig Drugs"},{"issue":"11","key":"3180_CR110","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.1016\/j.bmc.2008.04.032","volume":"16","author":"C-R Su","year":"2008","unstructured":"Su C-R et al (2008a) Total synthesis of phenanthroindolizidine alkaloids (\u00b1)-antofine,(\u00b1)-deoxypergularinine, and their dehydro congeners and evaluation of their cytotoxic activity. Bioorg Med Chem 16(11):6233\u20136241","journal-title":"Bioorg Med Chem"},{"issue":"11","key":"3180_CR111","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.1016\/j.bmc.2008.04.032","volume":"16","author":"C-R Su","year":"2008","unstructured":"Su C-R et al (2008b) Total synthesis of phenanthroindolizidine alkaloids (\u00b1)-antofine, (\u00b1)-deoxypergularinine, and their dehydro congeners and evaluation of their cytotoxic activity. Bioorg Med Chem 16(11):6233\u20136241","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"3180_CR112","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.phytol.2008.12.006","volume":"2","author":"G Subramaniam","year":"2009","unstructured":"Subramaniam G et al (2009) A benzopyrroloisoquinoline alkaloid from Ficus fistulosa. Phytochem Lett 2(2):88\u201390","journal-title":"Phytochem Lett"},{"issue":"3","key":"3180_CR113","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"3180_CR114","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10456-011-9208-2","volume":"14","author":"N Thairu","year":"2011","unstructured":"Thairu N et al (2011) Angiogenesis as a therapeutic target in arthritis in 2011: learning the lessons of the colorectal cancer experience. Angiogenesis 14:223\u2013234","journal-title":"Angiogenesis"},{"issue":"6","key":"3180_CR115","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1046\/j.1365-2710.2001.00368.x","volume":"26","author":"Z Topcu","year":"2001","unstructured":"Topcu Z (2001) DNA topoisomerases as targets for anticancer drugs. J Clin Pharm Ther 26(6):405\u2013416","journal-title":"J Clin Pharm Ther"},{"issue":"17","key":"3180_CR116","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.1021\/ol061435f","volume":"8","author":"A Toribio","year":"2006","unstructured":"Toribio A et al (2006) Novel seco-dibenzopyrrocoline alkaloid from Cryptocarya o ubatchensis. Org Lett 8(17):3825\u20133828","journal-title":"Org Lett"},{"key":"3180_CR117","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/BF00396440","volume":"69","author":"SR Venkatachalam","year":"1982","unstructured":"Venkatachalam SR, Mulchandani NB (1982) Isolation of phenanthroindolizidine alkaloids and a novel biphenylhexahydroindolizine alkaloid from Ficus hispida. Naturwissenschaften 69:287\u2013288","journal-title":"Naturwissenschaften"},{"issue":"2","key":"3180_CR118","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1021\/jo8021633","volume":"74","author":"K Wang","year":"2009","unstructured":"Wang K et al (2009) Iron (III) chloride catalyzed oxidative coupling of aromatic nuclei. J Org Chem 74(2):935\u2013938","journal-title":"J Org Chem"},{"key":"3180_CR119","first-page":"678","volume":"40","author":"C-H Wang","year":"2013","unstructured":"Wang C-H et al (2013) Multi-drug resistance reversal agents from natural medicine and their advances. J Int Pharma Res 40:678\u2013687","journal-title":"J Int Pharma Res"},{"issue":"5","key":"3180_CR120","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/cbdd.12340","volume":"84","author":"Z Wang","year":"2014","unstructured":"Wang Z et al (2014) Design, synthesis, anti-tobacco mosaic virus (TMV) activity, and SARs of 7-methoxycryptopleurine derivatives. Chem Biol Drug Des 84(5):531\u2013542","journal-title":"Chem Biol Drug Des"},{"issue":"8","key":"3180_CR121","first-page":"561","volume":"16","author":"M Wang","year":"2018","unstructured":"Wang M et al (2018) Application of alkaloids in reversing multidrug resistance in human cancers. Chin J Nat Med 16(8):561\u2013571","journal-title":"Chin J Nat Med"},{"issue":"2","key":"3180_CR122","first-page":"141","volume":"2","author":"X Wang","year":"2019","unstructured":"Wang X, Zhang H, Chen X (2019) Drug resistance and combating drug resistance in cancer. Cancer Drug Resist 2(2):141","journal-title":"Cancer Drug Resist"},{"issue":"19","key":"3180_CR123","doi-asserted-by":"publisher","first-page":"6560","DOI":"10.1016\/j.bmc.2006.06.009","volume":"14","author":"L Wei","year":"2006","unstructured":"Wei L et al (2006) Antitumor agents 251: synthesis, cytotoxic evaluation, and structure\u2013activity relationship studies of phenanthrene-based tylophorine derivatives (PBTs) as a new class of antitumor agents. Bioorg Med Chem 14(19):6560\u20136569","journal-title":"Bioorg Med Chem"},{"issue":"11","key":"3180_CR124","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/nm.2537","volume":"17","author":"SM Weis","year":"2011","unstructured":"Weis SM, Cheresh DA (2011) Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med 17(11):1359\u20131370","journal-title":"Nat Med"},{"key":"3180_CR125","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/jlac.19697210120","volume":"721","author":"W Wiegrebe","year":"1969","unstructured":"Wiegrebe W et al (1969) Alkaloide aus Cynanchum vincetoxicum (L.) Pers. Justus Liebigs Annalen der Chemie 721:154\u2013162","journal-title":"Justus Liebigs Annalen der Chemie"},{"issue":"6","key":"3180_CR126","first-page":"1934578X1200700","volume":"7","author":"T-S Wu","year":"2012","unstructured":"Wu T-S, Su C-R, Lee K-H (2012) Cytotoxic and anti-HIV phenanthroindolizidine alkaloids from Cryptocarya chinensis. Nat Prod Commun 7(6):1934578X1200700608","journal-title":"Nat Prod Commun"},{"issue":"5","key":"3180_CR127","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1021\/jf304905k","volume":"61","author":"M Wu","year":"2013","unstructured":"Wu M et al (2013) Synthesis and antiviral activities of antofine analogues with different C-6 substituent groups. J Agric Food Chem 61(5):1030\u20131035","journal-title":"J Agric Food Chem"},{"issue":"1","key":"3180_CR128","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11030-013-9484-4","volume":"18","author":"M Wu","year":"2014","unstructured":"Wu M et al (2014) Design, synthesis, and anti-tobacco mosaic virus (TMV) activity of glycoconjugates of phenanthroindolizidines alkaloids. Mol Diversity 18(1):25\u201337","journal-title":"Mol Diversity"},{"key":"3180_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.postharvbio.2019.110961","volume":"157","author":"Z Xin","year":"2019","unstructured":"Xin Z et al (2019) Isolation of antofine from Cynanchum atratum BUNGE (Asclepiadaceae) and its antifungal activity against Penicillium digitatum. Postharvest Biol Technol 157:110961","journal-title":"Postharvest Biol Technol"},{"issue":"4","key":"3180_CR130","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.bbrc.2007.01.065","volume":"354","author":"C-W Yang","year":"2007","unstructured":"Yang C-W et al (2007) Anti-inflammatory effects of 7-methoxycryptopleurine and structure\u2013activity relations of phenanthroindolizidines and phenanthroquinolizidines. Biochem Biophys Res Commun 354(4):942\u2013948","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"3180_CR131","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1021\/ol902819j","volume":"12","author":"X Yang","year":"2010","unstructured":"Yang X et al (2010) A new synthetic strategy for E-Ring SAR Study of Antofine and Cryptopleurine Analogues. Org Lett 12(7):1416\u20131419","journal-title":"Org Lett"},{"issue":"14","key":"3180_CR132","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.1021\/jm200330s","volume":"54","author":"X Yang","year":"2011","unstructured":"Yang X et al (2011) Antitumor agents 288: design, synthesis, SAR, and biological studies of novel heteroatom-incorporated antofine and cryptopleurine analogues as potent and selective antitumor agents. J Med Chem 54(14):5097\u20135107","journal-title":"J Med Chem"},{"issue":"15","key":"3180_CR133","doi-asserted-by":"publisher","first-page":"6751","DOI":"10.1021\/jm3001218","volume":"55","author":"X Yang","year":"2012","unstructured":"Yang X et al (2012) Antitumor agents 295. E-ring hydroxylated antofine and cryptopleurine analogues as antiproliferative agents: design, synthesis, and mechanistic studies. J Me Chem 55(15):6751\u20136761","journal-title":"J Me Chem"},{"issue":"24","key":"3180_CR134","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1080\/14786419.2019.1574787","volume":"34","author":"Y-C Yang","year":"2020","unstructured":"Yang Y-C et al (2020) Phytochemical and antitumor studies on Cynanchum mongolicum (Maxim.) Kom. Nat Prod Res 34(24):3437\u20133443","journal-title":"Nat Prod Res"},{"issue":"11","key":"3180_CR135","first-page":"1024","volume":"21","author":"Y Yao","year":"2001","unstructured":"Yao Y et al (2001) Research of chemistry and bioactivity of active compounds antiphytovirus in Cynanchum konmarovii. Chinese J Org Chem 21(11):1024","journal-title":"Chinese J Org Chem"},{"issue":"15","key":"3180_CR136","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1002\/ejoc.201300200","volume":"2013","author":"W Ying","year":"2013","unstructured":"Ying W, Herndon JW (2013) Total synthesis of (+)-antofine and (\u2013)-cryptopleurine. Eur J Org Chem 2013(15):3112\u20133122","journal-title":"Eur J Org Chem"},{"key":"3180_CR137","doi-asserted-by":"publisher","unstructured":"Zeeshan M et al (2023) In silico molecular docking and ADMET evaluation for investigating the anti-cancer potential of ketoprofen amides against cyclooxygenase-2 (COX-2). Res Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-2446268\/v1","DOI":"10.21203\/rs.3.rs-2446268\/v1"},{"issue":"8","key":"3180_CR138","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1021\/jo500013e","volume":"79","author":"Y Zheng","year":"2014","unstructured":"Zheng Y, Liu Y, Wang Q (2014) Collective asymmetric synthesis of (\u2212)-antofine, (\u2212)-cryptopleurine, (\u2212)-tylophorine, and (\u2212)-tylocrebrine with tert-butanesulfinamide as a chiral auxiliary. J Org Chem 79(8):3348\u20133357","journal-title":"J Org Chem"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03180-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03180-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03180-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T04:41:39Z","timestamp":1730176899000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03180-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,6]]},"references-count":138,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["3180"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03180-x","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,6]]},"assertion":[{"value":"22 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}